This study describes the outcome of 25 travellers with severe malaria who returned from malaria-endemic regions and were treated at 7 centres in Europe with intravenous artesunate. Among these 25 patients, one child and 24 adults (mean ± SD age 44.1 ± 16.1 years), 10 patients received the dosing regimen for artesunate initially recommended by WHO and 11 received artesunate, 2.4 mg/kg/dose.
This paper describes a small retrospective observational study of Israeli travellers presenting to a tropical medicine clinic with a history of prolonged (4 weeks), non-traumatic arthralgia or arthritis over a 5 year period.
The first annual meeting of the European hepatitis B and C surveillance network takes place on 23-24 March 2011. Since 2009, ECDC has worked on preparing the enhanced surveillance of hepatitis B and C at EU/EEA level by establishing a network for hepatitis B and C surveillance and by carrying out a survey on prevention and surveillance activities in the Member States.
The emergence of cholera in Haiti once again reminds us of the ferocity with which infectious diseases can strike and of the complex interactions of emerging infectious diseases with social conditions, human migration, and the ecosystem.
Location:Hilton Am Stadtpark, Vienna, Austria
Organized by:International Society for Infectious Diseases (ISID)
This descriptive study, based on national surveillance data of reported malaria cases, travelers’ statistics and data on malaria chemoprophylaxis prescriptions, estimates the incidence and trends of imported malaria in the Netherlands.
This paper describes the results of an open-label randomized trial, comparing the use of artesunate and quinine for the treatment of severe Plasmodium falciparum malaria in children in 11 African countries.
The appearance of West Nile virus in New York in 1999 and the unprecedented panzootic that followed, have stimulated a major research effort in the western hemisphere and a new interest in the presence of this virus in the Old World. This review considers current understanding of the natural history of this pathogen, with particular regard to transmission in Europe.
Following an outbreak of chikungunya in the area of Ravenna, Italy in Summer 2007 and the increasing presence of Aedes albopictus mosquitoes in Europe, ECDC has prepared a Chikungunya Communications Toolkit. It provides template materials containing background information and practical advice on chikungunya prevention and control and is targeting the general public, travellers and health practitioners.
It is important to protect yourself from mosquito bites when staying in the affected areas in order to prevent becoming infected with the virus. How can travelers prevent mosquito bites?